Stay updated on Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New page revision notes and version identifiers were added, including Revision: v3.4.3 with date 2026-03-05 and additional dates 2027-02, 2026-03-03, and 2026-03. The previous revision v3.4.2 is listed under deletions.
    Difference
    0.4%
    Check dated 2026-03-11T14:50:05.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    A new site revision (v3.4.2) has been added, and the older revision (v3.4.1) along with the government funding status notice have been removed. These are administrative page maintenance updates and do not modify study details, eligibility criteria, or results.
    Difference
    0.4%
    Check dated 2026-02-11T05:35:03.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A site-wide notice about potential data inaccuracy due to funding issues has been added, and the page version was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T04:18:35.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added 'Show glossary' and the 'Last Update Submitted that Met QC Criteria' label, and updated footer notes to 'No FEAR Act Data' and 'Revision: v3.4.0'. Removed the previous 'Last Update Submitted that met QC Criteria' label, 'No FEAR Act data' note, and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T02:00:32.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The change is a minor metadata update (Revision: v3.3.4 added; v3.3.3 removed) that does not affect study content or user-visible information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:23:51.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Added a Locations section with New Jersey and New York headings and removed the separate New Jersey Locations and New York Locations subsections. Revision updated from v3.3.2 to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T20:37:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.